IGF-1/GH axis enhances losartan treatment in Lama2-related muscular dystrophy

Abstract excerpt

As the complexities of dystrophic pathology have been elucidated over the last few years, it has become increasingly clear that primary monogenetic defects result in multiple secondary pathologies capable of autonomously driving disease progression. Consequently, single-mode therapies fail to comprehensively ameliorate all aspects of pathology. Lama2-related muscular dystrophy (MDC1A) is a devastating congenital...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Muscle Physiology and Disorders
• Share to Telomeres, Telomerase, and Senescence
• Share to Ubiquitin and proteasome pathways